A new avenue for lithium: Intervention in traumatic brain injury

ACS Chemical Neuroscience

Volumn 5, Issue 6, 2014, Pages 422-433

  Leeds, Peter R ^a   Yu, Fengshan ^a,b   Wang, Zhifei ^a   Chiu, Chi Tso ^a   Zhang, Yumin ^b   Leng, Yan ^a   Linares, Gabriel R ^a   Chuang, De Maw ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Anti inflammation; behavioral deficits and cognitive improvements; combined therapy treatment; controlled cortical impact; functional recovery; GSK 3 (glycogen synthase kinase 3) inhibitor; lithium; mood stabilizer; neuroprotection; neuroregeneration; preclinical model; TBI (traumatic brain injury)

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2; GLYCOGEN SYNTHASE KINASE 3; GROWTH FACTOR; HEAT SHOCK PROTEIN 70; LITHIUM; NEUROTROPHIN; PROTEIN BCL 2; TAU PROTEIN; TRANSCRIPTION FACTOR; LITHIUM DERIVATIVE; NEUROPROTECTIVE AGENT;

APOPTOSIS; BIPOLAR DISORDER; BLOOD BRAIN BARRIER; BLOOD LEVEL; CLINICAL RESEARCH; DOWN REGULATION; GLIA; HUMAN; MICROGLIA; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TRAUMATIC BRAIN INJURY; UPREGULATION; ANIMAL; BRAIN INJURIES; PATHOPHYSIOLOGY;

ANIMALS; BRAIN INJURIES; HUMANS; LITHIUM COMPOUNDS; NEUROPROTECTIVE AGENTS;

EID: 84902658167     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500040g     Document Type: Review

References (174)

1. Maas, A. I., Stocchetti, N., and Bullock, R. (2008) Moderate and severe traumatic brain injury in adults Lancet Neurol. 7 (8) 728-741
2. Faul, M., Xu, L., Wald, M. M., and Coronado, V. G. (2010) Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Atlanta, GA.
3. Loane, D. J. and Faden, A. I. (2010) Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies Trends Pharmacol. Sci. 31 (12) 596-604
4. Algattas, H. and Huang, J. H. (2014) Traumatic brain injury pathophysiology and treatments: early, intermediate, and late phases post-injury Int. J. Mol. Sci. 15 (1) 309-341
5. Kabadi, S. V. and Faden, A. I. (2014) Neuroprotective strategies for traumatic brain injury: improving clinical translation Int. J. Mol. Sci. 15 (1) 1216-1236
6. Blennow, K., Hardy, J., and Zetterberg, H. (2012) The neuropathology and neurobiology of traumatic brain injury Neuron 76 (5) 886-899
7. McIntosh, T. K., Smith, D. H., Meaney, D. F., Kotapka, M. J., Gennarelli, T. A., and Graham, D. I. (1996) Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms Lab. Invest. 74 (2) 315-342
8. Ursano, R. J., Goldenberg, M., Zhang, L., Carlton, J., Fullerton, C. S., Li, H., Johnson, L., and Benedek, D. (2010) Posttraumatic stress disorder and traumatic stress: from bench to bedside, from war to disaster Ann. N.Y. Acad. Sci. 1208, 72-81
9. Margulies, S. and Hicks, R. (2009) Combination Therapies for Traumatic Brain Injury Workshop, L. Combination therapies for traumatic brain injury: prospective considerations J. Neurotrauma 26 (6) 925-939
10. Vacheron-Trystram, M. N., Braitman, A., Cheref, S., and Auffray, L. (2004) Antipsychotics in bipolar disorders L'Encephale 30 (5) 417-424
11. 3Li lithium metallotherapeutics. In Metallotherapeutic Drugs and Metal-Based Diagnostic Agents: The Use of Metals in Medicine (Gielen, M. and Teikink, E. R. T., Eds.), pp 1-18, John Wieley & Sons Ltd, Chichester, West Sussex, UK.
12. Cade, J. F. (1949) Lithium salts in the treatment of psychotic excitement Med. J. Aust. 2 (10) 349-352
13. Chen, C. H., Lee, C. S., Lee, M. T., Ouyang, W. C., Chen, C. C., Chong, M. Y., Wu, J. Y., Tan, H. K., Lee, Y. C., Chuo, L. J., Chiu, N. Y., Tsang, H. Y., Chang, T. J., Lung, F. W., Chiu, C. H., Chang, C. H., Chen, Y. S., Hou, Y. M., Chen, C. C., Lai, T. J., Tung, C. L., Chen, C. Y., Lane, H. Y., Su, T. P., Feng, J., Lin, J. J., Chang, C. J., Teng, P. R., Liu, C. Y., Chen, C. K., Liu, I. C., Chen, J. J., Lu, T., Fan, C. C., Wu, C. K., Li, C. F., Wang, K. H., Wu, L. S., Peng, H. L., Chang, C. P., Lu, L. S., Chen, Y. T., Cheng, A. T., and Taiwan Bipolar, C. (2014) Variant GADL1 and response to lithium therapy in bipolar I disorder New Engl. J. Med. 370 (2) 119-128
14. Chuang, D. M. (2004) Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases? Crit. Rev. Neurobiol. 16 (1-2) 83-90
15. Chiu, C. T., Wang, Z., Hunsberger, J. G., and Chuang, D. M. (2013) Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder Pharmacol. Rev. 65 (1) 105-142
16. Young, W. (2009) Review of lithium effects on brain and blood Cell Transplant. 18 (9) 951-975
17. Chiu, C. T. and Chuang, D. M. (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders Pharmacol. Ther. 128 (2) 281-304
18. Chuang, D. M., Wang, Z., and Chiu, C. T. (2011) GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke Front. Mol. Neurosci. 4, 15
19. Jope, R. S. and Roh, M. S. (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions Curr. Drug Targets 7 (11) 1421-1434
20. Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., and Berk, M. (2013) Potential mechanisms of action of lithium in bipolar disorder. Current understanding CNS Drugs 27 (2) 135-153
21. Dodd, S., Maes, M., Anderson, G., Dean, O. M., Moylan, S., and Berk, M. (2013) Putative neuroprotective agents in neuropsychiatric disorders Prog. Neuro-Psychopharmacol. Biol. Psychiatry 42, 135-145
22. Moore, G. J., Bebchuk, J. M., Hasanat, K., Chen, G., Seraji-Bozorgzad, N., Wilds, I. B., Faulk, M. W., Koch, S., Glitz, D. A., Jolkovsky, L., and Manji, H. K. (2000) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2′s neurotrophic effects? Biol. Psychiatry 48 (1) 1-8
23. Silverstone, P. H., Wu, R. H., O'Donnell, T., Ulrich, M., Asghar, S. J., and Hanstock, C. C. (2003) Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients Int. Clin. Psychopharmacol. 18 (2) 73-79
24. Chen, X., Wen, W., Malhi, G. S., Ivanovski, B., and Sachdev, P. S. (2007) Regional gray matter changes in bipolar disorder: a voxel-based morphometric study Aust. N. Z. J. Psychiatry 41 (4) 327-336
25. Chang, K., Karchemskiy, A., Barnea-Goraly, N., Garrett, A., Simeonova, D. I., and Reiss, A. (2005) Reduced amygdalar gray matter volume in familial pediatric bipolar disorder J. Am. Acad. Child Adolesc. Psychiatry 44 (6) 565-573
26. Monkul, E. S., Malhi, G. S., and Soares, J. C. (2005) Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress? Aust. N. Z. J. Psychiatry 39 (4) 222-226
27. Bearden, C. E., Thompson, P. M., Dalwani, M., Hayashi, K. M., Lee, A. D., Nicoletti, M., Trakhtenbroit, M., Glahn, D. C., Brambilla, P., Sassi, R. B., Mallinger, A. G., Frank, E., Kupfer, D. J., and Soares, J. C. (2007) Greater cortical gray matter density in lithium-treated patients with bipolar disorder Biol. Psychiatry 62 (1) 7-16
28. Lyoo, I. K., Dager, S. R., Kim, J. E., Yoon, S. J., Friedman, S. D., Dunner, D. L., and Renshaw, P. F. (2010) Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study Neuropsychopharmacology 35 (8) 1743-5170
29. Cousins, D. A., Aribisala, B., Nicol Ferrier, I., and Blamire, A. M. (2013) Lithium, gray matter, and magnetic resonance imaging signal Biol. Psychiatry 73 (7) 652-657
30. Woodgett, J. R. (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A EMBO J. 9 (8) 2431-2438
31. Liang, M. H. and Chuang, D. M. (2006) Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation J. Biol. Chem. 281 (41) 30479-30484
32. Liang, M. H. and Chuang, D. M. (2007) Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival J. Biol. Chem. 282 (6) 3904-3917
33. Klein, P. S. and Melton, D. A. (1996) A molecular mechanism for the effect of lithium on development Proc. Natl. Acad. Sci. U.S.A. 93 (16) 8455-8459
34. Stambolic, V., Ruel, L., and Woodgett, J. R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells Curr. Biol. 6 (12) 1664-1668
35. Chalecka-Franaszek, E. and Chuang, D. M. (1999) Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons Proc. Natl. Acad. Sci. U.S.A. 96 (15) 8745-8750
36. Jope, R. S. (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol. Sci. 24 (9) 441-443
37. Beaulieu, J. M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., and Caron, M. G. (2008) A beta-arrestin 2 signaling complex mediates lithium action on behavior Cell 132 (1) 125-316
38. Meijer, L., Flajolet, M., and Greengard, P. (2004) Pharmacological inhibitors of glycogen synthase kinase 3 Trends Pharmacol. Sci. 25 (9) 471-480
39. Rowe, M. K. and Chuang, D. M. (2004) Lithium neuroprotection: molecular mechanisms and clinical implications Expert Rev. Mol. Med. 6 (21) 1-18
40. Huang, H. C. and Klein, P. S. (2006) Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease Current Drug Targets 7 (11) 1389-1397
41. Rowe, M. K., Wiest, C., and Chuang, D. M. (2007) GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder Neurosci. Biobehav. Rev. 31 (6) 920-931
42. Li, X. and Jope, R. S. (2010) Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35 (11) 2143-2154
43. King, M. K., Pardo, M., Cheng, Y., Downey, K., Jope, R. S., and Beurel, E. (2014) Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments Pharmacol. Ther. 141 (1) 1-12
44. Ozaki, N. and Chuang, D. M. (1997) Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain J. Neurochem. 69 (6) 2336-2344
45. Chen, R. W., Qin, Z. H., Ren, M., Kanai, H., Chalecka-Franaszek, E., Leeds, P., and Chuang, D. M. (2003) Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection J. Neurochem. 84 (3) 566-575
46. Zhang, F., Phiel, C. J., Spece, L., Gurvich, N., and Klein, P. S. (2003) Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3 J. Biol. Chem. 278 (35) 33067-33077
47. O'Brien, W. T., Huang, J., Buccafusca, R., Garskof, J., Valvezan, A. J., Berry, G. T., and Klein, P. S. (2011) Glycogen synthase kinase-3 is essential for beta-arrestin-2 complex formation and lithium-sensitive behaviors in mice J. Clin. Invest. 121 (9) 3756-3762
48. Freland, L. and Beaulieu, J. M. (2012) Inhibition of GSK3 by lithium, from single molecules to signaling networks Front. Mol. Neurosci. 5, 14
49. Beurel, E. and Jope, R. S. (2009) Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain J. Neuroinflammation 6, 9
50. Wang, Z. F., Fessler, E. B., and Chuang, D. M. (2011) Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models Acta Pharmacol. Sinica 32 (12) 1433-1445
51. Beaulieu, J. M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., and Caron, M. G. (2008) Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency Proc. Natl. Acad. Sci. U.S.A. 105 (4) 1333-1338
52. Gould, T. D., Chen, G., and Manji, H. K. (2004) In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3 Neuropsychopharmacolog 29 (1) 32-38
53. Kaidanovich-Beilin, O., Milman, A., Weizman, A., Pick, C. G., and Eldar-Finkelman, H. (2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus Biol. Psychiatry 55 (8) 781-784
54. Omata, N., Chiu, C. T., Moya, P. R., Leng, Y., Wang, Z., Hunsberger, J. G., Leeds, P., and Chuang, D. M. (2011) Lentivirally mediated GSK-3beta silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice Int. J. Neuropsychopharmacol. 14 (5) 711-717
55. Rosa, A. O., Kaster, M. P., Binfare, R. W., Morales, S., Martin-Aparicio, E., Navarro-Rico, M. L., Martinez, A., Medina, M., Garcia, A. G., Lopez, M. G., and Rodrigues, A. L. (2008) Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice Prog. Neuro-Psychopharmacol. Biol. Psychiatry 32 (6) 1549-1556
56. Pan, J. Q., Lewis, M. C., Ketterman, J. K., Clore, E. L., Riley, M., Richards, K. R., Berry-Scott, E., Liu, X., Wagner, F. F., Holson, E. B., Neve, R. L., Biechele, T. L., Moon, R. T., Scolnick, E. M., Petryshen, T. L., and Haggarty, S. J. (2011) AKT kinase activity is required for lithium to modulate mood-related behaviors in mice Neuropsychopharmacology 36 (7) 1397-1411
57. Nonaka, S., Hough, C. J., and Chuang, D. M. (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx Proc. Natl. Acad. Sci. U.S.A. 95 (5) 2642-2647
58. Hashimoto, R., Hough, C., Nakazawa, T., Yamamoto, T., and Chuang, D. M. (2002) Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation J. Neurochem. 80 (4) 589-597
59. Hashimoto, R., Fujimaki, K., Jeong, M. R., Christ, L., and Chuang, D. M. (2003) Lithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N -methyl- d -aspartate receptor-mediated excitotoxicity FEBS Lett. 538 (1-3) 145-148
60. Hashimoto, R., Takei, N., Shimazu, K., Christ, L., Lu, B., and Chuang, D. M. (2002) Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity Neuropharmacology 43 (7) 1173-1179
61. Kopnisky, K. L., Chalecka-Franaszek, E., Gonzalez-Zulueta, M., and Chuang, D. M. (2003) Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities Neuroscience 116 (2) 425-435
62. Chen, R. W. and Chuang, D. M. (1999) Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity J. Biol. Chem. 274 (10) 6039-6042
63. Kang, H. J., Noh, J. S., Bae, Y. S., and Gwag, B. J. (2003) Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase Cgamma Mol. Pharmacol. 64 (2) 228-234
64. Everall, I. P., Bell, C., Mallory, M., Langford, D., Adame, A., Rockestein, E., and Masliah, E. (2002) Lithium ameliorates HIV-gp120-mediated neurotoxicity Mol. Cell. Neurosci. 21 (3) 493-501
65. Maes, M., Song, C., Lin, A. H., Pioli, R., Kenis, G., Kubera, M., and Bosmans, E. (1999) In vitro immunoregulatory effects of lithium in healthy volunteers Psychopharmacology 143 (4) 401-407
66. Hull, M., Lee, E., Lee, T., Anand, N., LaLone, V., and Parameswaran, N. (2014) Lithium chloride induces TNFalpha in mouse macrophages via MEK-ERK-dependent pathway J. Cell. Biochem. 115 (1) 71-80
67. De Sarno, P., Axtell, R. C., Raman, C., Roth, K. A., Alessi, D. R., and Jope, R. S. (2008) Lithium prevents and ameliorates experimental autoimmune encephalomyelitis J. Immunol. 181 (1) 338-345
68. Plant, K. E., Anderson, E., Simecek, N., Brown, R., Forster, S., Spinks, J., Toms, N., Gibson, G. G., Lyon, J., and Plant, N. (2009) The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1 Toxicol. Appl. Pharmacol. 235 (1) 124-134
69. Farah, R., Khamisy-Farah, R., Amit, T., Youdim, M. B., and Arraf, Z. (2013) Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray study Cell. Mol. Neurobiol. 33 (3) 411-420
70. Hunsberger, J. G., Fessler, E. B., Chibane, F. L., Leng, Y., Maric, D., Elkahloun, A. G., and Chuang, D. M. (2013) Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions Am. J. Transl. Res. 5 (4) 450-464
71. Hashimoto, K., Shimizu, E., and Iyo, M. (2004) Critical role of brain-derived neurotrophic factor in mood disorders Brain Res. Rev. 45 (2) 104-114
72. Post, R. M. (2007) Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications J. Psychiatr. Res. 41 (12) 979-990
73. Angelucci, F., Aloe, L., Jimenez-Vasquez, P., and Mathe, A. A. (2003) Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression Int. J. Neuropsychopharmacol. 6 (3) 225-231
74. Angelucci, F., Mathe, A. A., and Aloe, L. (2004) Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia Prog. Brain Res. 146, 151-165
75. Gama, C. S., Andreazza, A. C., Kunz, M., Berk, M., Belmonte-de-Abreu, P. S., and Kapczinski, F. (2007) Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder Neurosci. Lett. 420 (1) 45-48
76. Yasuda, S., Liang, M. H., Marinova, Z., Yahyavi, A., and Chuang, D. M. (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons Mol. Psychiatry 14 (1) 51-59
77. Frey, B. N., Andreazza, A. C., Cereser, K. M., Martins, M. R., Valvassori, S. S., Reus, G. Z., Quevedo, J., and Kapczinski, F. (2006) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania Life Sci. 79 (3) 281-286
78. Fukumoto, T., Morinobu, S., Okamoto, Y., Kagaya, A., and Yamawaki, S. (2001) Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain Psychopharmacology 158 (1) 100-106
79. Omata, N., Murata, T., Takamatsu, S., Maruoka, N., Mitsuya, H., Yonekura, Y., Fujibayashi, Y., and Wada, Y. (2008) Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treatment Bipolar Disord. 10 (3) 360-368
80. Rantamaki, T., Knuuttila, J. E., Hokkanen, M. E., and Castren, E. (2006) The effects of acute and long-term lithium treatments on trkB neurotrophin receptor activation in the mouse hippocampus and anterior cingulate cortex Neuropharmacology 50 (4) 421-417
81. Wu, R., Fan, J., Zhao, J., Calabrese, J. R., and Gao, K. (2014) The relationship between neurotrophins and bipolar disorder Expert Rev. Neurother. 14 (1) 51-65
82. Leyhe, T., Eschweiler, G. W., Stransky, E., Gasser, T., Annas, P., Basun, H., and Laske, C. (2009) Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease J. Alzheimer's Dis. 16 (3) 649-656
83. Machado-Vieira, R., Dietrich, M. O., Leke, R., Cereser, V. H., Zanatto, V., Kapczinski, F., Souza, D. O., Portela, L. V., and Gentil, V. (2007) Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode Biol. Psychiatry 61 (2) 142-144
84. Tramontina, J. F., Andreazza, A. C., Kauer-Sant'anna, M., Stertz, L., Goi, J., Chiarani, F., and Kapczinski, F. (2009) Brain-derived neurotrophic factor serum levels before and after treatment for acute mania Neurosci. Lett. 452 (2) 111-113
85. Rybakowski, J. K. and Suwalska, A. (2010) Excellent lithium responders have normal cognitive functions and plasma BDNF levels Int. J. Neuropsychopharmacol. 13 (5) 617-622
86. de Sousa, R. T., van de Bilt, M. T., Diniz, B. S., Ladeira, R. B., Portela, L. V., Souza, D. O., Forlenza, O. V., Gattaz, W. F., and Machado-Vieira, R. (2011) Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study Neurosci. Lett. 494 (1) 54-56
87. D'Addario, C., Dell'Osso, B., Palazzo, M. C., Benatti, B., Lietti, L., Cattaneo, E., Galimberti, D., Fenoglio, C., Cortini, F., Scarpini, E., Arosio, B., Di Francesco, A., Di Benedetto, M., Romualdi, P., Candeletti, S., Mari, D., Bergamaschini, L., Bresolin, N., Maccarrone, M., and Altamura, A. C. (2012) Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII Neuropsychopharmacology 37 (7) 1647-1655
88. Dias, V. V., Brissos, S., Frey, B. N., Andreazza, A. C., Cardoso, C., and Kapczinski, F. (2009) Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder Bipolar Disord. 11 (6) 663-671
89. Frey, B. N., Andreazza, A. C., Rosa, A. R., Martins, M. R., Valvassori, S. S., Reus, G. Z., Hatch, J. P., Quevedo, J., and Kapczinski, F. (2006) Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania Behav. Pharmacol. 17 (4) 311-318
90. Hellweg, R., Lang, U. E., Nagel, M., and Baumgartner, A. (2002) Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats Mol. Psychiatry 7 (6) 604-608
91. Mudo, G., Jiang, X. H., Timmusk, T., Bindoni, M., and Belluardo, N. (1996) Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine Epilepsia 37 (2) 198-207
92. Walz, J. C., Frey, B. N., Andreazza, A. C., Cereser, K. M., Cacilhas, A. A., Valvassori, S. S., Quevedo, J., and Kapczinski, F. (2008) Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania J. Psychiatr. Res. 42 (5) 416-421
93. Matsumoto, T. and Claesson-Welsh, L. (2001) VEGF receptor signal transduction Sci. Signaling 2001 (112) re21
94. Ferrara, N., Gerber, H. P., and LeCouter, J. (2003) The biology of VEGF and its receptors Nat. Med. 9 (6) 669-676
95. Patan, S. (2004) Vasculogenesis and angiogenesis Cancer Treat. Res. 117, 3-32
96. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 (6573) 435-439
97. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 (6573) 439-442
98. Rosenstein, J. M., Mani, N., Khaibullina, A., and Krum, J. M. (2003) Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons J. Neurosci. 23 (35) 11036-11044
99. Jin, K. L., Mao, X. O., and Greenberg, D. A. (2000) Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia Proc. Natl. Acad. Sci. U.S.A. 97 (18) 10242-10247
100. Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Van Dorpe, J., Hellings, P., Gorselink, M., Heymans, S., Theilmeier, G., Dewerchin, M., Laudenbach, V., Vermylen, P., Raat, H., Acker, T., Vleminckx, V., Van Den Bosch, L., Cashman, N., Fujisawa, H., Drost, M. R., Sciot, R., Bruyninckx, F., Hicklin, D. J., Ince, C., Gressens, P., Lupu, F., Plate, K. H., Robberecht, W., Herbert, J. M., Collen, D., and Carmeliet, P. (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration Nat. Genet. 28 (2) 131-138
101. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., and Greenberg, D. A. (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia J. Clin. Invest. 111 (12) 1843-1851
102. Chodobski, A., Chung, I., Kozniewska, E., Ivanenko, T., Chang, W., Harrington, J. F., Duncan, J. A., and Szmydynger-Chodobska, J. (2003) Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury Neuroscience 122 (4) 853-867
103. Mellergard, P., Sjogren, F., and Hillman, J. (2010) Release of VEGF and FGF in the extracellular space following severe subarachnoidal haemorrhage or traumatic head injury in humans Br. J. Neurosurg. 24 (3) 261-267
104. Rosenstein, J. M., Mani, N., Silverman, W. F., and Krum, J. M. (1998) Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 95 (12) 7086-7091
105. Krum, J. M. and Khaibullina, A. (2003) Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair Exp. Neurol. 181 (2) 241-257
106. Thau-Zuchman, O., Shohami, E., Alexandrovich, A. G., and Leker, R. R. (2010) Vascular endothelial growth factor increases neurogenesis after traumatic brain injury J. Cereb. Blood Flow Metab. 30 (5) 1008-1016
107. Thau-Zuchman, O., Shohami, E., Alexandrovich, A. G., and Leker, R. R. (2012) Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury J. Mol. Neurosci. 47 (1) 166-172
108. Thau-Zuchman, O., Shohami, E., Alexandrovich, A. G., and Leker, R. R. (2012) Subacute treatment with vascular endothelial growth factor after traumatic brain injury increases angiogenesis and gliogenesis Neuroscience 202, 334-341
109. Wang, Z., Tsai, L. K., Munasinghe, J., Leng, Y., Fessler, E. B., Chibane, F., Leeds, P., and Chuang, D. M. (2012) Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke Stroke 43 (9) 2430-2436
110. Ren, M., Senatorov, V. V., Chen, R. W., and Chuang, D. M. (2003) Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model Proc. Natl. Acad. Sci. U.S.A. 100 (10) 6210-6215
111. Bian, Q., Shi, T., Chuang, D. M., and Qian, Y. (2007) Lithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbils Brain Res. 1184, 270-276
112. Kim, Y. R., van Meer, M. P., Tejima, E., Murata, Y., Mandeville, J. B., Dai, G., Chuang, D. M., Rosen, B. R., and Lo, E. H. (2008) Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia Stroke 39 (2) 439-447
113. Yu, F., Wang, Z., Tchantchou, F., Chiu, C. T., Zhang, Y., and Chuang, D. M. (2012) Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury J. Neurotrauma 29 (2) 362-374
114. Yu, F., Zhang, Y., and Chuang, D. M. (2012) Lithium reduces BACE1 overexpression, beta amyloid accumulation, and spatial learning deficits in mice with traumatic brain injury J. Neurotrauma 29 (13) 2342-2351
115. Yu, F., Wang, Z., Tanaka, M., Chiu, C. T., Leeds, P., Zhang, Y., and Chuang, D. M. (2013) Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury J. Neurosurg. 119 (3) 766-773
116. Du, W. J., Li, J. K., Wang, Q. Y., Hou, J. B., and Yu, B. (2009) Lithium chloride preconditioning optimizes skeletal myoblast functions for cellular cardiomyoplasty in vitro via glycogen synthase kinase-3beta/beta-catenin signaling Cells Tissues Organs 190 (1) 11-19
117. Kaga, S., Zhan, L., Altaf, E., and Maulik, N. (2006) Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium J. Mol. Cell. Cardiol. 40 (1) 138-147
118. Silva, R., Martins, L., Longatto-Filho, A., Almeida, O. F., and Sousa, N. (2007) Lithium prevents stress-induced reduction of vascular endothelium growth factor levels Neurosci. Lett. 429 (1) 33-38
119. Guo, S., Arai, K., Stins, M. F., Chuang, D. M., and Lo, E. H. (2009) Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes Stroke 40 (2) 652-655
120. Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., Elmquist, J. K., Gerard, R. D., Burgess, S. C., Hammer, R. E., Mangelsdorf, D. J., and Kliewer, S. A. (2007) Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab. 5 (6) 415-425
121. Kharitonenkov, A. and Larsen, P. (2011) FGF21 reloaded: challenges of a rapidly growing field Trends Endocrinol. Metab. 22 (3) 81-86
122. Colantuoni, C., Lipska, B. K., Ye, T., Hyde, T. M., Tao, R., Leek, J. T., Colantuoni, E. A., Elkahloun, A. G., Herman, M. M., Weinberger, D. R., and Kleinman, J. E. (2011) Temporal dynamics and genetic control of transcription in the human prefrontal cortex Nature 478 (7370) 519-523
123. Leng, Y., Liang, M. H., Ren, M., Marinova, Z., Leeds, P., and Chuang, D. M. (2008) Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition J. Neurosci. 28 (10) 2576-2588
124. Leng, Y., Wang, Z., Tsai, L. K., Leeds, P., Fessler, E. B., Wang, J., and Chuang, D. M. (2014) FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers Mol. Psychiatry 10.1038/mp.2013.192
125. Senatorov, V. V., Ren, M., Kanai, H., Wei, H., and Chuang, D. M. (2004) Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease Mol. Psychiatry 9 (4) 371-385
126. Chen, G., Rajkowska, G., Du, F., Seraji-Bozorgzad, N., and Manji, H. K. (2000) Enhancement of hippocampal neurogenesis by lithium J. Neurochem. 75 (4) 1729-1734
127. Son, H., Yu, I. T., Hwang, S. J., Kim, J. S., Lee, S. H., Lee, Y. S., and Kaang, B. K. (2003) Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus J. Neurochem. 85 (4) 872-881
128. Yu, I. T., Kim, J. S., Lee, S. H., Lee, Y. S., and Son, H. (2003) Chronic lithium enhances hippocampal long-term potentiation, but not neurogenesis, in the aged rat dentate gyrus Biochem. Biophys. Res. Commun. 303 (4) 1193-1198
129. Kim, J. S., Chang, M. Y., Yu, I. T., Kim, J. H., Lee, S. H., Lee, Y. S., and Son, H. (2004) Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo J. Neurochem. 89 (2) 324-336
130. Silva, R., Mesquita, A. R., Bessa, J., Sousa, J. C., Sotiropoulos, I., Leao, P., Almeida, O. F., and Sousa, N. (2008) Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta Neuroscience 152 (3) 656-669
131. Wexler, E. M., Geschwind, D. H., and Palmer, T. D. (2008) Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation Mol. Psychiatry 13 (3) 285-292
132. Hashimoto, R., Senatorov, V., Kanai, H., Leeds, P., and Chuang, D. M. (2003) Lithium stimulates progenitor proliferation in cultured brain neurons Neuroscience 117 (1) 55-61
133. Su, H., Chu, T. H., and Wu, W. (2007) Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord Exp. Neurol. 206 (2) 296-307
134. McKenzie, G., Ward, G., Stallwood, Y., Briend, E., Papadia, S., Lennard, A., Turner, M., Champion, B., and Hardingham, G. E. (2006) Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals BMC Cell Biol. 7, 10
135. Espinosa, L., Ingles-Esteve, J., Aguilera, C., and Bigas, A. (2003) Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways J. Biol. Chem. 278 (34) 32227-32235
136. Bachmann, R. F., Wang, Y., Yuan, P., Zhou, R., Li, X., Alesci, S., Du, J., and Manji, H. K. (2009) Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage Int. J. Neuropsychopharmacol. 12 (6) 805-822
137. Li, Q., Li, H., Roughton, K., Wang, X., Kroemer, G., Blomgren, K., and Zhu, C. (2010) Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia Cell Death Dis. 1, e56
138. Shapira, M., Licht, A., Milman, A., Pick, C. G., Shohami, E., and Eldar-Finkelman, H. (2007) Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury Mol. Cell. Neurosci. 34 (4) 571-577
139. Zhu, Z. F., Wang, Q. G., Han, B. J., and William, C. P. (2010) Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice Brain Res. Bull. 83 (5) 272-277
140. Dash, P. K., Johnson, D., Clark, J., Orsi, S. A., Zhang, M., Zhao, J., Grill, R. J., Moore, A. N., and Pati, S. (2011) Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcome PLoS One 6 (9) e24648
141. Ekici, M. A., Uysal, O., Cikriklar, H. I., Ozbek, Z., Turgut Cosan, D., Baydemir, C., Kazanci, B., and Hafizoglu, D. (2014) Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury Eur. Rev. Med. Pharmacol. Sci. 18 (1) 10-27
142. Sivanandam, T. M. and Thakur, M. K. (2012) Traumatic brain injury: a risk
143. Spikman, J. M., Timmerman, M. E., Milders, M. V., Veenstra, W. S., and van der Naalt, J. (2012) Social cognition impairments in relation to general cognitive deficits, injury severity, and prefrontal lesions in traumatic brain injury patients J. Neurotrauma 29 (1) 101-111
144. Olsson, A., Csajbok, L., Ost, M., Hoglund, K., Nylen, K., Rosengren, L., Nellgard, B., and Blennow, K. (2004) Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury J. Neurol. 251 (7) 870-876
145. Raby, C. A., Morganti-Kossmann, M. C., Kossmann, T., Stahel, P. F., Watson, M. D., Evans, L. M., Mehta, P. D., Spiegel, K., Kuo, Y. M., Roher, A. E., and Emmerling, M. R. (1998) Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluid J. Neurochem. 71 (6) 2505-2509
146. Uryu, K., Chen, X. H., Martinez, D., Browne, K. D., Johnson, V. E., Graham, D. I., Lee, V. M., Trojanowski, J. Q., and Smith, D. H. (2007) Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans Exp. Neurol. 208 (2) 185-192
147. Roberts, G. W., Gentleman, S. M., Lynch, A., and Graham, D. I. (1991) beta A4 amyloid protein deposition in brain after head trauma Lancet 338 (8780) 1422-1423
148. Hooper, C., Killick, R., and Lovestone, S. (2008) The GSK3 hypothesis of Alzheimer's disease J. Neurochem. 104 (6) 1433-1439
149. Phiel, C. J., Wilson, C. A., Lee, V. M., and Klein, P. S. (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides Nature 423 (6938) 435-439
150. Wei, H., Leeds, P. R., Qian, Y., Wei, W., Chen, R., and Chuang, D. (2000) beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment Eur. J. Pharmacol. 392 (3) 117-123
151. Loane, D. J., Pocivavsek, A., Moussa, C. E., Thompson, R., Matsuoka, Y., Faden, A. I., Rebeck, G. W., and Burns, M. P. (2009) Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury Nat. Med. 15 (4) 377-379
152. Loane, D. J., Washington, P. M., Vardanian, L., Pocivavsek, A., Hoe, H. S., Duff, K. E., Cernak, I., Rebeck, G. W., Faden, A. I., and Burns, M. P. (2011) Modulation of ABCA1 by an LXR agonist reduces beta-amyloid levels and improves outcome after traumatic brain injury J. Neurotrauma 28 (2) 225-236
153. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 95 (11) 6448-6453
154. Rockenstein, E., Torrance, M., Adame, A., Mante, M., Bar-on, P., Rose, J. B., Crews, L., and Masliah, E. (2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation J. Neurosci. 27 (8) 1981-1991
155. Ly, P. T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., and Song, W. (2013) Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes J. Clin. Invest. 123 (1) 224-235
156. Chuang, D. M., Leng, Y., Marinova, Z., Kim, H. J., and Chiu, C. T. (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions Trends Neurosci. 32 (11) 591-601
157. Dash, P. K., Orsi, S. A., and Moore, A. N. (2009) Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury Neuroscience 163 (1) 1-8
158. Dash, P. K., Orsi, S. A., Zhang, M., Grill, R. J., Pati, S., Zhao, J., and Moore, A. N. (2010) Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats PLoS One 5 (6) e11383
159. Shein, N. A., Grigoriadis, N., Alexandrovich, A. G., Simeonidou, C., Lourbopoulos, A., Polyzoidou, E., Trembovler, V., Mascagni, P., Dinarello, C. A., and Shohami, E. (2009) Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury FASEB J. 23 (12) 4266-4275
160. Wang, Z., Leng, Y., Tsai, L. K., Leeds, P., and Chuang, D. M. (2011) Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition J. Cereb. Blood Flow Metab. 31 (1) 52-57
161. Zhang, B., West, E. J., Van, K. C., Gurkoff, G. G., Zhou, J., Zhang, X. M., Kozikowski, A. P., and Lyeth, B. G. (2008) HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats Brain Res. 1226, 181-191
162. Chiu, C. T., Liu, G., Leeds, P., and Chuang, D. M. (2011) Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease Neuropsychopharmacology 36 (12) 2406-2421
163. Feng, H. L., Leng, Y., Ma, C. H., Zhang, J., Ren, M., and Chuang, D. M. (2008) Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model Neuroscience 155 (3) 567-572
164. Tsai, L. K., Leng, Y., Wang, Z., Leeds, P., and Chuang, D. M. (2010) The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms Neuropsychopharmacology 35 (11) 2225-2237
165. Tsai, L. K., Wang, Z., Munasinghe, J., Leng, Y., Leeds, P., and Chuang, D. M. (2011) Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model Stroke 42 (10) 2932-2939
166. Johnson, V. E., Stewart, W., and Smith, D. H. (2013) Axonal pathology in traumatic brain injury Exp. Neurol. 246, 35-43
167. Strich, S. J. (1956) Diffuse degeneration of the cerebral white matter in severe dementia following head injury J. Neurol Neurosurg. Psychiatry 19 (3) 163-185
168. Lipton, M. L., Gellella, E., Lo, C., Gold, T., Ardekani, B. A., Shifteh, K., Bello, J. A., and Branch, C. A. (2008) Multifocal white matter ultrastructural abnormalities in mild traumatic brain injury with cognitive disability: a voxel-wise analysis of diffusion tensor imaging J. Neurotrauma 25 (11) 1335-1342
169. Wang, G., Zhang, J., Hu, X., Zhang, L., Mao, L., Jiang, X., Liou, A. K., Leak, R. K., Gao, Y., and Chen, J. (2013) Microglia/macrophage polarization dynamics in white matter after traumatic brain injury J. Cereb. Blood Flow Metab. 33 (12) 1864-1874
170. Calabrese, E., Du, F., Garman, R. H., Johnson, G. A., Riccio, C., Tong, L. C., and Long, J. B. (2014) Diffusion tensor imaging reveals white matter injury in a rat model of repetitive blast-induced traumatic brain injury J. Neurotrauma 10.1089/neu.2013.3144
171. Bigler, E. D. (2013) Traumatic brain injury, neuroimaging, and neurodegeneration Front. Hum. Neurosci. 7, 395
172. Dill, J., Wang, H., Zhou, F., and Li, S. (2008) Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS J. Neurosci. 28 (36) 8914-8928
173. Benedetti, F., Bollettini, I., Barberi, I., Radaelli, D., Poletti, S., Locatelli, C., Pirovano, A., Lorenzi, C., Falini, A., Colombo, C., and Smeraldi, E. (2013) Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder Neuropsychopharmacology 38 (2) 313-327
174. Liu, X. S., Chopp, M., Kassis, H., Jia, L. F., Hozeska-Solgot, A., Zhang, R. L., Chen, C., Cui, Y. S., and Zhang, Z. G. (2012) Valproic acid increases white matter repair and neurogenesis after stroke Neuroscience 220, 313-321